Recent reports have demonstrated that Bordetella pertussis has invasive behavior in vivo and in vitro. In this study, we investigated the ability of a virulent strain, avirulent mutants, and mutants deficient in specific virulence factors to enter and survive intracellularly in human macrophages in vitro. Uptake of virulent B. pertussis was dose dependent and occurred in the absence of serum or specific antibody, with entry occurring via a microfilament-dependent phagocytic process. The virulent wild-type parental strain was internalized and persisted intracelularly over the 3 days of experiments, as determined by transmission electron microscopy and by recovery of viable plate counts. This is the first report of long-term survival of B. pertussis in human macrophages. Avirulent mutants entered macrophages, but at only an average of 1.5% of virulent parental levels, and did not survive intracellularly. Mutants which did not express adenylate cyclase toxin, filamentous hemagglutinin, or pertussis toxin had decreased abilities to enter and to survive inside macrophages. The results suggest that the internalization process, as well as intracellular survival, is virulence dependent and that mutations which inactivate expression of virulence factors may affect both. The ability of B. pertussis to enter and persist inside macrophages may be important not only for survival of the bacteria but also in the pathogenesis of whooping cough.
The human pathogen Bordetella pertussis causes an acute and chronic respiratory infection which is localized to the tracheobronchial tree, causing the major childhood disease whooping cough (17, 32, 59) . B. pertussis is typically viewed as a noninvasive microorganism which produces a large array of potential virulence factors that may play a role in the pathogenesis of pertussis. These factors include pertussis toxin (PT) (40, 46) , filamentous hemagglutinin (FHA) (32, 45) , endotoxin (17, 32, 59) , adenylate cyclase toxin (AC) (8, 19) , heat-labile toxin (65) , tracheal cytotoxin (21) , agglutinogens (55) , and pertactin (6, 29) .
Previous reports suggest that B. pertussis may have invasive capabilities and the ability to survive intracellularly in mammalian cells in vitro and in vivo. Crawford and Fishel were the first, in 1959, to report that B. pertussis could invade and persist in HeLa and mouse kidney tissue culture cell lines (12) . They suggested that the intracellular localization of B. pertussis may be an important survival mechanism in the disease process.
Later work by Gray and Cheers, using the mouse intranasal infection model, reported that B. pertussis caused a persistent low-level lung infection that lasted 4 weeks, which they called immunological complaisance (22) . In further investigations, they found B. pertussis present in mouse lung macrophages early in the infection, and the organism persisted through the complaisant period (7) .
Woods et al. investigated the ability of virulent and avirulent strains to survive and persist in a rat model for respiratory infection with B. pertussis (64) . Avirulent B. pertussis was not recovered after 3 days from lungs of infected rats, while virulent B. pertussis was recovered on days 3 and 7 after inoculation but not on days 10 and 14. Recovery of viable B. pertussis from lungs of infected rats * Corresponding author.
was again possible on day 21. Electron micrographs of lungs of infected animals revealed that the lung cells contained B. pertussis which appeared viable at 14 days. The authors propose that B. pertussis was not recoverable on days 10 and 14 because the microbe was residing intracellularly inside lung cells, perhaps alveolar macrophage (64) .
Ewanowich et al. recently reported that Bordetella parapertussis has the ability to invade both HeLa cells and human respiratory epithelial tissue in vitro (15) . The bacteria persisted but did not multiply in the cells over the 7-h period of the study. Ewanowich and associates reported similar observations of invasion and persistence in HeLa cells with use of B. pertussis (14) . Lee et al. also reported invasion and intracellular survival of virulent B. pertussis in a HeLa cell model (27) (43) .
Studies investigating the interaction of B. pertussis with human polymorphonuclear leukocytes (PMN) have revealed that the microbe survives intracellularly within the phagocytes (54) . Intracellular survival appears to be due in part to inhibition of phagosome-lysosome fusion in PMN, yet respiratory burst activity of the phagocytes occurs at normal levels (53) .
Several recent studies have shown that B. pertussis can also persist intracellularly within human macrophages (4, 18, 47) . Cumulatively, these results are intriguing because they suggest that Bordetella spp. have the ability to enter and persist in mammalian cells.
In this study, we further investigated the interaction of virulent and mutant strains of B. pertussis with human blood macrophages and the role of the microbe's virulence factors in uptake and intracellular survival. The results demonstrate that once virulent B. pertussis is internalized into macrophages, it can survive and persist intracellularly.
MATERIALS AND METHODS
Bacterial strains. B.pertussis strains used for this work are listed in Table 1 . Stock cultures of B. pertussis were stored at -70°C as a suspension in Stainer-Scholte medium containing 50% glycerol (54) . Bacteria were inoculated onto charcoal agar (Difco Laboratories, Detroit, Mich.) supplemented with 10% horse blood, grown at 37C for 2 to 3 days, and used in experiments. In experiments using the conditional TnStacl AC mutant BC67, the mutant was grown on charcoal plates with or without the addition of 1 mM ,-D-thiogalactopyranoside (IPTG; U.S. Biochemical Corp., Cleveland, Ohio). In the presence of IPTG, BC67 expresses wild-type levels of AC, while in its absence, no AC is expressed (9, 10) .
Macrophage isolation. Mononuclear cells were isolated from venous blood treated with EDTA by Ficoll-Hypaque gradient centrifugation as previously described (3) (14) because of the concern that over the extended incubation period of 3 days, the antibiotic would penetrate into the macrophages. Hand and King-Thompson have reported that gentamicin can indeed penetrate phagocytes and inactive intracellular bacteria (24) . In initial experiments, gentamicin (100 ,ug/ml) was used to kill extracellular bacteria, but upon extended incubation (1 to 3 days), gentamicin appeared to penetrate into the macrophages at levels that killed the intracellular B. pertussis (data not shown). Thus, the alternate method of complement serum killing was used to circumvent this problem.
Incubation of B. pertussis alone in the presence of RPMI-15% NS for 1 h killed >99.9995% of the microbes (reducing numbers of viable bacteria from 2 x 107 to 2 x 103). Upon extended incubation in RPMI-15% NS for 1 day, no viable B. pertussis was recovered. Further control experiments were also done to demonstrate the requirement for viable macrophages for B. pertussis survival in the macrophage infection assay. Macrophage sonic extracts (from 2 x 105 macrophages) were added to RPMI-15% NS containing B. pertussis, and viability was monitored over 3 days. Results of these studies demonstrated that B. pertussis did not replicate or survive under these conditions, with no viable counts recovered by day 1. Therefore, in the macrophage infection model, the presence of viable B. pertussis requires internalization into viable macrophages to evade serum killing. All mutants used in these studies (Table 1) were tested and found to be susceptible to complement killing at levels observed for BP338.
After extracellular killing of bacteria by 15% NS, monolayers were washed, fresh RPMI-15% NS was added, and cultures were incubated for 0, 1, 2, or 3 days. RPMI with 15% NS was observed to maintain its killing activity over the 3 days of the studies. In control experiments, uninfected macrophage monolayers were incubated with RPMI-15% NS for 1, 2, or 3 days, with the spent medium being recovered and tested for its ability to kill BP338 (3 x 106 bacteria per assay). It was found that spent medium, from all time points, killed BP338 and reduced viable numbers to 99.995% after 1 h of incubation. With extended incubation, no viable counts were recovered. B.pertussis killing was due to complement-mediated killing, since the addition to media of 10 mM EDTA, which chelates Ca2+ and blocks complement activation, eliminated all serum killing (data not shown).
After 0, 1, 2, or 3 days, monolayers were lysed by the addition of sterile distilled water containing 10 mM EDTA (to inactivate complement-mediated killing), and dilution plate counts were made on charcoal agar plates for detection of viable bacteria.
Treatment of macrophage monolayers with inhibitors. In some experiments, macrophage monolayers were treated either with cytochalasin D (CD) at 1.0 and 2.5 F±g/ml or with monodanyslcadaverine (MDC) at 25 and 50 ,uM (both purchased from Sigma). Monolayers were preincubated for 1 h and during the infection assay with the inhibitors (15, 49 (Fig. 1) , statistically there was no significant difference between viable counts at days 0 to 3 at both 100:1 and 400:1 infection ratios (P < 0.05). The percentage of initial inoculum which was internalized by the macrophage monolayer at time zero peaked at the 100:1 infection ratio, with 12.4% of the infectious dose being internalized.
Viability of the macrophage monolayers over the 3 days of the studies was monitored via trypan blue exclusion. Monolayers infected at a 10:1, 50:1, or 100:1 infection ratio had levels of viability comparable to those observed with control uninfected macrophages (91 to 98% viability over 3 days). Only at the 400:1 infection ratio was a decrease in macrophage viability observed, with 90 and 80% viability observed by days 2 and 3, respectively (data not shown).
EM examination of macrophages infected with B. pertussis. EM was performed to verify that B. pertussis BP338 had indeed been internalized by macrophages in the infection assay and was present intracellularly. Figure 2 shows typical observations of intracellular B. pertussis in the cytoplasm of macrophages on days 0 and 3. On day 0 ( Fig. 2A and B) after initial uptake, numerous B. penussis organisms were present in tightly fitting phagosomes in the cytoplasm of the macrophages. The microbes were always observed to be contained in phagosomes and not free in the cell cytoplasm. On day 3, microbes were still present singly in phagosomes, suggesting that no intracellular multiplication of the microbes had occurred (Fig. 2C and D) . Similar EM results were obtained on days 1 and 2 of these studies (data not shown).
Mechanism of B. pertussis entry into macrophages. Two basic mechanisms are used by classic intracellular parasites for internalization into mammalian cells: microfilament-dependent phagocytosis and receptor-mediated endocytosis (37) . Studies were done with CD, which inhibits microfilament formation and thus blocks phagocytosis (16) , and MDC, which inhibits receptor-mediated endocytosis (49) .
Macrophage monolayers were preincubated with the inhibitors for 1 h before and during the infection assays. The levels of inhibitors used did not decrease the viability of either the macrophages or B. pertussis BP338 (data not shown).
CD at 1.0 and 2.5 ,ug/ml inhibited B. pertussis uptake into macrophage to 8 and 1.7% of control BP338 levels (P < 0.01) (Fig. 3) (9, 10) . BC67 was grown either with (BC67 + IPTG) or without (BC67 -IPTG) IPTG, and the ability of BC67 to enter macrophages was determined. In these experiments, monolayers were cultured either with or without the addition of 20 mM IPTG to maintain expression of AC by BC67 when required. BC67 + IPTG entered macrophages at levels not statistically different from those of virulent BP338, while uptake of BC67 -IPTG dropped to levels similar to those of BP348 (AC-) ( Table 2 ). Uptake of BC67 + IPTG was significantly greater than uptake of BC67 -IPTG and BP348 (P < 0.05).
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Strains BP101 (AFHA, with a 2.4-kb deletion in the FHA gene), BP-TOX6 (PT-, with a 4.7-kb deletion in the PT gene), and BP101-TOX6 (AFHA PT-) were used. BP101, BP-TOX6, and BP101-TOX6 had decreased abilities to enter macrophages ( Table 2 ). The internalization levels for BP101, BP-TOX6, and BP101-TOX6 were 7, 35, and 14%, respectively, of parental levels. The level of BP338 internalization was significantly higher (P < 0.05) than those of all mutants except BC67 + IPTG. Figure 4 shows the ability of the various B. pertussis mutants to survive intracellularly in macrophages over 3 VOL. 60, 1992 days. Viable counts dropped by greater than 3 log units over the 3 days of the study with the vir strains. By 3 days, no viable BP537 was detected and only 10 CFU of BP347 per monolayer was detected. AC mutants BP348 and BC67 -IPTG persisted better than the other B. pertussis mutants tested, while BC67 + IPTG survived at levels comparable to those of BP338. The PT and FHA mutants were found to have decreased abilities to survive intracellularly in macrophages, with viable counts dropping over 3 days (Fig. 4) . On days 1, 2, and 3 of the studies, levels of viable intracellular BP338 (at a 100:1 infection ratio) were significantly higher than levels for all mutants studied except BC67 + IPTG (P < 0.05).
DISCUSSION
The results of this study demonstrate that B. pertussis has the ability to enter, survive, and persist intracellularly in human macrophages. Virulent B. pertussis was able to enter macrophages, in the absence of serum, via a microfilamentdependent phagocytic process which was inhibited by CD ( Fig. 1 and 3) . Intracellular survival and persistence of B. pertussis over the 3 days of the studies were confirmed by viable plate counts and by EM examination of infected a Monolayers were infected with virulent strain BP338 and various B. pertussis mutants at a 100:1 infection ratio. After infection (2 h), monolayers were incubated for 1 h with 15% NS to kill extracellular bacteria and washed, macrophages were lysed, and viable plate counts were determined.
b Percent uptake of B. pertussis strains compared with levels of BP338 uptake (100%) standard deviation. Each experiment was performed at least six times in duplicate. macrophage monolayers (Fig. 2) . The level of uptake of B. pertussis at the 100:1 infection ratio (12.4% of the infectious dose was internalized) was comparable to levels reported for such invasive microbes as Yersinia pseudotuberculosis, Salmonella typhimurium, and Shigella flexneri (16, 51) . Ewanowich et al. reported comparable levels of invasion by B.
pertussis versus S. flemneri and Salmonella hadar in their
HeLa cell model (14) . This is the first report of long-term survival of B. pertussis in human macrophages in vitro. Saukkonen et al. reported survival in human macrophages in short-term culture for a period of 6 h (47). Studies utilizing HeLa cells as an internalization model have been done for 7 h and up to 9 days (12, 14, 27) .
The direct entry into macrophages, without opsonization by complement or antibody, is in contrast to the strict requirement for opsonization by antipertussis antibody to induce uptake (phagocytosis) of B.pertussis by human PMN (53, 54) . Without antibody opsonization, no internalization of the bacteria into PMN occurs.
While virulent B. pertussis survived inside macrophages after uptake at the 100:1 and 400:1 infection ratios, no intracellular multiplication was observed ( Fig. 1 and 2) . At lower infection ratios of 10:1 and 50:1, B. pertussis was able to be internalized, but numbers of viable intracellular bacteria dropped significantly over the 3 days of the studies, suggesting that killing occurred. These results suggest that for B. pertussis to persist inside macrophages, a critical number of virulent microbes must be present intracellularly. This requirement is also reflected in the results of experiments using mutant strains. Since uptake levels are so low for the vir mutants and the other mutant strains, the intracellular number of bacteria required for survival cannot be attained. It is possible that if avirulent mutants could attain a critical intracellular number, they would be able to survive. Another possibility is that this critical intracellular bacterial number is required so that levels of exotoxins (AC, PT, or others factors) high enough to inhibit normal macrophage bacterial killing or metabolic processes are produced. PT (8, 19, 20, 30) . PT also has been reported to inhibit chemotaxis, lysosomal enzyme release, and superoxide production in PMN (2, 52 Fig. 4 ). These results demonstrate that the internalization process, as well as intracellular survival, is vir dependent. Uptake and intracellular survival in the HeLa cell model has also been reported to be vir dependent (14, 27) . The products of the vir, or bvgAS, locus coordinately regulate expression of most virulence factors of B. pertussis (13, 23, 26, 35, 44, 48, 56) . The vir locus is a member of a family of twocomponent bacterial sensory transduction systems which senses environmental signals and responds via regulation of virulence gene expression (10, 30, 31, 51) .
The AC mutants used in this study were found to have significantly decreased abilities to enter and to survive intracellularly in macrophages (Table 2 and Fig. 4) . In experiments using the AC conditional expression mutant BC67, in the presence of IPTG, AC was expressed and the mutant was able to enter and persist in monolayers at parental levels. Without IPTG, AC was not expressed and levels of BC67 internalization and persistence dropped to those obtained with the AC-mutant BP348. These observations may suggest that AC is important in the uptake process and in intracellular survival. (14) .
Purified AC has been demonstrated to induce increases in intracellular cyclic AMP (cAMP) levels in phagocytes (8, 19, 20) , and increased levels of intracellular cAMP have been shown to impede phagosome-lysosome fusion in PMN and in macrophages (31, 61) . Thus AC, by increasing intracellular levels of cAMP in macrophages, may block phagosomelysosome fusion, thereby allowing intracellular survival. In studies of PMN-B. pertussis interactions, intracellular B. pertussis inhibited phagosome-lysosome fusion and the bacteria were not killed (54) .
Results of experiments using PT and FHA mutants suggest the requirement of these factors for optimal uptake and survival of B. pertussis in macrophages (Table 2 and Fig. 4 (41, 42, 47, 57, 58) . PT can function as an adhesion, by interaction with certain carbohydrates on cell surfaces (47) . FHA interacts with macrophages via two mechanisms: by binding to galactosecontaining glycoconjugates on the phagocyte and by the interaction of an Arg-Gly-Asp (RGD) sequence of FHA with the macrophage integrin complement receptor 3 (CR3) (41, 42, 47) . FHA binding to CR3 of macrophages induces internalization of the microorganism into the phagocyte (47). These observations are intriguing because many intracellular pathogens interact with macrophage CR3 to induce phagocytosis. CR3 has been found to mediate uptake of Legionella pneumophila, Mycobacterium leprae, Histoplasma capsulatum, Leishmania donovani, and Y. pseudotuberculosis into mammalian cells (5, 25, 39, 50, 63) .
Lower levels (CFU per monolayer) of the double mutant BP101-TOX6 than of the single FHA and PT mutants were recovered by day 3, suggesting a synergistic effect of the loss of both PT and FHA expression (Fig. 4) . The role that FHA plays in intracellular survival is not known. In mammalian cells, PT, as demonstrated for AC, can induce increases in intracellular cAMP levels which could impede phagosomelysosome fusion and other phagocyte functions (8, 19, 20, 31, 61) .
While FHA mutants, PT mutants, or double mutants had significantly decreased abilities to enter and survive in macrophages, the mutants could still localize within phagocytes, suggesting that other ligands can induce entry of B. pertussis. One such ligand may be the recently identified B. pertussis surface protein pertactin (6, 29) . This outer membrane protein has been cloned and sequenced and found to contain an RGD sequence that promotes adherence of B. pertussis to tissue culture cells (6, 28, 29) . Studies using HEp-2 cells demonstrated that pertactin plays a role in the adherence and entry process (43) . Recent studies by Leininger et al. found that the RGD sequence of pertactin mediated uptake into HeLa cells, while the RGD sequence of FHA had no effect (28) . The role of pertactin in attachment and entry into macrophages needs further investigation. The results of these studies suggest that B. pertussis has multiple methods for uptake into mammalian cells. These multiple bacterial ligands which induce entry may act synergistically, or they may allow the microbe to enter various target cell types, depending on the presence of appropriate receptors.
The reported ability of viable B. pertussis to enter and survive in macrophages (18, 47) , PMN (53, 54) , and nonphagocytic cells (12, 14, 15, 27) and the ability of its exoproducts to suppress various macrophage functions strongly suggest that B. pertussis is invasive and that host macrophage responses may play an important role in the defense against pertussis. The macrophage response (cellmediated immunity) plays a critical role in the control of infections caused by classical intracellular pathogens such as Listeria monocytogenes, L. pneumophila, Mycobacteriun tuberculosis, and others (37) . In support of the potential importance of cell-mediated immunity in whooping cough are the reported cases of both adults and children with human immunodeficiency virus infection who developed pertussis infections (1, 4, 38) . Most intriguing is the paper of Bromberg et al., which reported the presence of intracellular B. pertussis within pulmonary alveolar macrophage recovered from bronchoalveolar lavage specimens from pediatric patients infected with human immunodeficiency virus (4). This is the first direct evidence that in vivo intracellular survival of B. pertussis may occur in human macrophages. The potential role that macrophages or cell-mediated immunity may play in pertussis immunity is a vital area for further investigation.
